Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_04233
Species: Homo sapiens
Position : chr2:16370000-16380000
Year: 2020
Title: Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: neuroblastoma
PMID:  33199677
MONDO: MONDO:0005072
Tissue: adrenal gland
Tissue Ontology ID: UBERON:0002369
Cell Source: Kelly
CVCL ID: CVCL_2092
Cell Type: neuroblastoma cell
Experiment Type: Enhancer activity assay, TF binding assay, Chromatin interaction assay
High Throughput Method: ChIP-seq; RNA-seq; ATAC-seq, 3C-seq; ATAC-seq; Hi-C; Oxford Nanopore sequencing
Low Throughput Method: qRT-PCR, and ChIP-qPCR
About Target Gene
Target gene : MYCN
About TF
TF name : PHOX2B
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
PHOX2B Hs_Neural_Crest_Differentiation_WP2064_79263 wikipathways 40
Enhancer Associated Network
Overlapping Enhancers (hg19) 2 found
Enhancer ID Position Tissue Cell Disease
E_04231 chr2:16370000-16380000 adrenal gland neuroblastoma cell neuroblastoma
E_04232 chr2:16370000-16380000 adrenal gland neuroblastoma cell neuroblastoma
Expression of Target Genes for the Enhancer